Trumping the Centers for Disease Control: A Case Comparison of the CDC’s Response to COVID-19, H1N1, and Ebola

AuthorEleanor Schiff,Daniel J. Mallinson
DOIhttp://doi.org/10.1177/00953997221112308
Published date01 January 2023
Date01 January 2023
Subject MatterArticles
https://doi.org/10.1177/00953997221112308
Administration & Society
2023, Vol. 55(1) 158 –183
© The Author(s) 2022
Article reuse guidelines:
sagepub.com/journals-permissions
DOI: 10.1177/00953997221112308
journals.sagepub.com/home/aas
Article
Trumping the Centers
for Disease Control:
A Case Comparison of
the CDC’s Response to
COVID-19, H1N1, and
Ebola
Eleanor Schiff1 and Daniel J. Mallinson2
Abstract
Despite being the richest and most prepared nation in the world, the U.S.
responded badly to the COVID-19 crisis. This paper examines the nature
of political control and the essence of bureaucratic failure for the Centers
for Disease Control and Prevention (CDC), an independent agency. In three
case studies, we analyze the CDC’s success in handling H1N1 and Ebola,
and its failures on COVID-19. We find that the CDC suffered not only
from political interference by the Trump Administration but also internal
organizational problems that muted its ability to respond effectively.
We conclude by offering policy prescriptions for addressing concerns of
bureaucratic autonomy and success at the CDC.
Keywords
bureaucratic failure, bureaucratic control, case comparison, COVID-19,
public health
1Penn State University, University Park, PA, USA
2Penn State Harrisburg, Middletown, PA, USA
Corresponding Author:
Eleanor Schiff, Department of Political Science, Penn State University, 203 Pond Laboratory
University Park, PA 16802, USA.
Email: eleanorschiff@gmail.com
1112308AAS0010.1177/00953997221112308Administration & SocietySchi and Mallinson
research-article2022
Schiff and Mallinson 159
The COVID-19 pandemic has been a disruptive force worldwide; however,
some countries have fared better than others in managing the disease. The
U.S., the richest country in the world, horribly mismanaged the crisis, leading
to over 700,000 deaths as of October 2021. Prior to the COVID-19 crisis,
bio-security researchers ranked the U.S. the most prepared for a pandemic
(Maxmen & Tollefson, 2020). At almost every important moment in the first
6 months of 2020, however, the U.S.’ response to COVID-19 was a dossier of
disaster.
During the Trump Administration, the American response was wholly
underwhelming and inadequate in controlling the virus, much to the baffle-
ment of Americans and the rest of the world. Poor countries, such as Vietnam
and Uganda, were, at least initially, more successful at controlling the virus
than the U.S., and rich countries like Taiwan quickly controlled the virus’
spread and experienced few deaths. Why was the U.S. in this position? Why
did the Centers for Disease Control and Prevention (CDC), one of the most
admired American government agencies across the world, largely fail in pro-
viding adequate guidance for COVID-19 when they successfully handled
past scares such as Ebola (2014) and H1N1 (2009)? In this case comparison
study, we will compare CDC’s largely failed response to COVID-19 to its
strong leadership during both the Ebola and H1N1 outbreaks. We argue that
CDC’s shortcomings in adequately handling COVID-19 are beyond the fee-
ble leadership of President Trump (NEJM Editors, 2020). They stem from
both bureaucratic intransigence and political interference.
This article begins with a brief background on the CDC as an institution,
including its typically stellar reputation in infectious disease control. We then
draw from the literatures on bureaucratic political control and bureaucratic
failure to examine how well the CDC is politically controlled. We then com-
pare the cases of H1N1, Ebola, and COVID-19 to examine the different out-
comes in similar situations. Finally, we present conclusions and offer potential
policy prescriptions to overcome the CDC’s current shortcomings.
Brief Background on the CDC
The CDC was founded in 1946 and headquartered in Atlanta to lead efforts
eradicating malaria in the American South. The agency has enjoyed wide-
spread public and Congressional support and confidence in the U.S. and
across the world for its scientific expertise and advice (Interlandi, 2021). It
offers guidance to states, physicians, researchers, and government officials
on a variety of topics from vaccine schedules for kids to contagious disease
mitigation. Its mission is to work “24/7 to protect America from health, safety
and security threats, both foreign and in the U.S.” (CDC, 2019b). Historically,

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT